Switching to Biosimilars: A conversation with Peter Taylor
Mrs Ailsa Bosworth, Chief Executive of the National Rheumatoid Arthritis Society (NRAS) and Chief Medical Advisor, Professor Peter Taylor discuss biosimilar medications for people with Rheumatoid Arthritis.
Comments (0)